Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec 23:12:60.
doi: 10.1186/s12986-015-0057-7. eCollection 2015.

Antidiabetic properties of dietary flavonoids: a cellular mechanism review

Affiliations
Review

Antidiabetic properties of dietary flavonoids: a cellular mechanism review

Ramachandran Vinayagam et al. Nutr Metab (Lond). .

Abstract

Background: Natural food products have been used for combating human diseases for thousands of years. Naturally occurring flavonoids including flavones, flavonols, flavanones, flavonols, isoflavones and anthocyanidins have been proposed as effective supplements for management and prevention of diabetes and its long-term complications based on in vitro and animal models.

Aim: To summarize the roles of dietary flavonoids in diabetes management and their molecular mechanisms.

Findings: Tremendous studies have found that flavonoids originated from foods could improve glucose metabolism, lipid profile, regulating the hormones and enzymes in human body, further protecting human being from diseases like obesity, diabetes and their complications.

Conclusion: In the current review, we summarize recent progress in understanding the biological action, mechanism and therapeutic potential of the dietary flavonoids and its subsequent clinical outcomes in the field of drug discovery in management of diabetes mellitus.

Keywords: Diabetes mellitus; Dietary flavonoids; Glycemic control; Hyperglycemia; Insulin secretion.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Schematic of the proposed role of flavonoids on management of blood glucose in diabetes. AKT; v-akt murine thymoma viral oncogene homolog, IRS; Insulin receptor substrate, HB; hemoglobin, HbA1c; Glycated hemoglobin, HMG-CoA :3-hydroxy-3-methylglutaryl-coenzyme A, IL-1β; Interleukin-1 beta, PI3K; Phosphatidylinositol-3-kinase, SREBP-1c; Sterol regulatory element-binding protein, TG; Triglycerides, VLDL; Very low density lipoprotein, (↑ Increase, ↓ Decrease)

References

    1. Devendra D, Liu E, Eisenbarth GS. Type 1diabetes: Recent developments. BMJ. 2004;328:750–54. doi: 10.1136/bmj.328.7442.750. - DOI - PMC - PubMed
    1. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008;26:2.
    1. International Diabetes Federation, Sixth edition. 2014.
    1. Kumar R, Laloo D, Hemalatha S. Diabetes mellitus: An overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity. Asian Pac J Trop Biomed. 2012;2:411–20. - PMC - PubMed
    1. Surveswaran S, Zhong Cai Y, Corke H, Sun M. Systematic evaluation of natural phenolic antioxidants from 133 Indian medicinal plants. Food Chem. 2007;102:938–53. doi: 10.1016/j.foodchem.2006.06.033. - DOI

LinkOut - more resources